Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 9 papers. Top paper: “Updated results of a phase IIa study to evaluate the clinical efficacy and safety of erdafitinib in Asian advanced cholangiocarcinoma (CCA) patients with FGFR alterations.”.
Yin-Hsun Feng, Yen-Yang Chen, Wu-Chou Su, Do-Youn Oh, Lin Shen +12 more
Daniel S.W. Tan, Ulrik Lassen, Serge Leyvraz, Yongmei Liu, Jyoti D. Patel +10 more
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas
Lin Shen, David S. Hong, Ray McDermott, Vicki L. Keedy, Michela Casanova +19 more
Joanne Xiu, Yasmine Baca, Hiroyuki Arai, Francesca Battaglin, Natsuko Kawanishi +17 more
Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matías Chacón +43 more
Joanne Xiu, Francesca Battaglin, Hiroyuki Arai, Shivani Soni, Wu Zhang +13 more
Liang Huang, Xin Zhang, Qiaofei Liu, Hou, L, Lin Shen
Wenjing Song, Yuanbo Liu, Jun Zhang, Lin Shen, X. Li +1 more
Lin Shen, Weitao Yang, Charles Lewis, Richard Wolfenden